DLD Asset Management Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
GLTA.U
Galata Acquisition Corp. Units, each consisting of one class A ordinary share and one-half of one warrant
GLTA.U
|
+$12.4M |
| 2 |
STMP
Stamps.com, Inc.
STMP
|
+$10.3M |
| 3 |
XEC
CIMAREX ENERGY CO
XEC
|
+$8.05M |
| 4 |
ATH
Athene Holding Ltd. Class A Common Shares
ATH
|
+$6.69M |
| 5 |
KSU
Kansas City Southern
KSU
|
+$5.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$22.1M |
| 2 |
PRAH
PRA Health Sciences, Inc.
PRAH
|
+$18.3M |
| 3 |
PFPT
Proofpoint, Inc.
PFPT
|
+$12.2M |
| 4 |
Royal Caribbean
RCL
|
+$11M |
| 5 |
MXIM
Maxim Integrated Products
MXIM
|
+$8.95M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 3.98% |
| 2 | Healthcare | 2.61% |
| 3 | Technology | 2.53% |
| 4 | Communication Services | 2.28% |
| 5 | Industrials | 2.2% |
Similar funds
DLD Asset Management's Q3 2021 Portfolio in Review
As of Q3 2021, DLD Asset Management held 193 positions worth $1.37B, down 4.9% from $1.44B the previous quarter. Its ten largest holdings account for 50% of the portfolio.
DLD Asset Management withdrew a net $836M in Q3 2021, closing 62 positions and reducing 8 holdings. Its most notable exit was Alexion Pharmaceuticals, an estimated $22.1M position sold in full.
By sector, the portfolio is most concentrated in Financials at 4% of assets, up from 3% a quarter earlier, followed by Healthcare and Technology.
Against the trend, DLD Asset Management opened a new position in Galata Acquisition Corp. Units, each consisting of one class A ordinary share and one-half of one warrant worth $12.4M.
- DLD Asset Management's largest Q3 2021 buy was Galata Acquisition Corp. Units, each consisting of one class A ordinary share and one-half of one warrant: 1,237,500 shares worth $12.4M.
- DLD Asset Management added most to Athene Holding Ltd. Class A Common Shares in Q3 2021, an estimated $6.69M increase.
- DLD Asset Management's biggest Q3 2021 reduction was IHS Markit Ltd. Common Shares, cutting an estimated $1.67M.
- DLD Asset Management fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $22.1M.
- DLD Asset Management's ten largest holdings make up 50% of its $1.37B portfolio in Q3 2021.
- DLD Asset Management opened 49 new positions and closed 62 in Q3 2021.
- DLD Asset Management's portfolio value fell 4.9% quarter-over-quarter to $1.37B.
Based on DLD Asset Management's 13F filing for Q3 2021, filed 12 Nov 2021.